arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Valion Bio, Inc.

VBIO

$2.75 ▲ +0.33 (+13.84%) at close

23 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Valion Bio, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $9.3M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -119.5% ↘

FCF / Share $-1.58 ↗

Trailing P/E —

Price / Book 2.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$146.00K

↑ +15.9% —

Net Income Profit after all expenses

$-6.20M

↓ -312.9% —

Operating Margin Operating profit as % of sales

-443.4%

— +0.1% —

FCF / Share Free cash flow per share

$-1.58

↑ +9.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Jan 31, 2022 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	—	—	—	15.9% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+98%)	-38.6% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-582%)	-79.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1088%)	—	-55.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-791%)	-13.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-263%)	-11.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-240%)	-12.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-256%)	-40.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-611%)	-69.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-969%)	-12.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-252%)	4.9% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-39%)	72.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+803%)	97.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1113%)	32.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+306%)	—	—	—	—	—
EPS Growth YoY (%)	0.9% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	11.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	7.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	49.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	59.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	85.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	99.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	84.5% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	95.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	90.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	58.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	94.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	77.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.2% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	50.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	70.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	60.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-312.9% Weak ↓ Weak Declining Year-over-year change in net income	-312.9% Weak ↓ Weak Declining Year-over-year change in net income	-92.9% Weak ↓ Weak Declining Year-over-year change in net income	-1.4% Weak ↓ Weak Declining Year-over-year change in net income	-1.4% Weak ↓ Weak Declining Year-over-year change in net income	-1.4% Weak ↓ Weak Declining Year-over-year change in net income	34.2% Excellent ↑ Excellent Improving Year-over-year change in net income	30.0% Excellent ↑ Excellent Improving Year-over-year change in net income	30.0% Excellent ↑ Excellent Improving Year-over-year change in net income	30.0% Excellent ↑ Excellent Improving Year-over-year change in net income	0.5% Caution ↓ Caution Declining Year-over-year change in net income	5.5% Fair ↓ Fair Declining Year-over-year change in net income	5.5% Fair ↑ Fair Improving Year-over-year change in net income	5.5% Fair ↑ Fair Improving Year-over-year change in net income	39.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-65.2% Weak → Weak Stable Year-over-year change in net income	-65.2% Weak Weak Year-over-year change in net income	-65.2% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	-16.7% Weak Weak Year-over-year change in free cash flow	—	—	—	92.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	90.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	44.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	22.1% Good Good Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	-32.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-45.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-45.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	-23.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-19.5% Weak Weak Compound annual revenue growth over 3 years	1.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Jan 31, 2022 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	-443.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3056%)	—	—	—	—	—	—	—	—	—	-443.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3058%)	-393.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2724%)	-327.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2282%)	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	-443.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3795%)	—	—	—	—	—	-469.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4013%)	-424.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3635%)	—	—	-489.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4179%)	—	-419.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3598%)	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	-498.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-496.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	-202.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-207.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.34x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Jan 31, 2022 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-119.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-45.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-54.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	16.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	23.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	70.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-19.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-43.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-29.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-15.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-146.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1074%)	-56.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-474%)	-83.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-656%)	-26.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-279%)	-40.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-372%)	-49.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-430%)	-58.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-488%)	-52.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-448%)	-35.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-336%)	-68.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-559%)	-62.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-518%)	-36.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-345%)	-66.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-546%)	-40.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-371%)	-62.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-514%)	-38.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-359%)	-27.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	-20.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-235%)	-28.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-287%)	23.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+56%)	37.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+151%)	115.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+668%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Jan 31, 2022 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-14.79x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.73x Weak Weak Operating income divided by interest expense Optimal: > 5x	-3.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-2.11M	$-7.21M	$-12.64M	$-3.45M	$-1.18M	$-669.00K	$-2.00M	$-2.19M	$-3.69M	$-1.67M	$-3.40M	—	—	$-5.17M	$-3.52M	$-6.33M	$-9.05M	—	$-12.97M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Jan 31, 2022 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	—	—	—	$0.11	$0.10	$0.12	—	$0.35	$0.59	$3.87	—	$4.03	$9.23	$31.78	—	$83.82	$93.33	$74.92	—	$182.72	$191.95	$235.31	—
Basic EPS, GAAP (USD)	$-2.17	$-2.23	$-1.35	$-1.97	$-2.19	$-2.52	$-1.46	$-3.91	$-5.44	$-17.18	$-166.20	$-25.17	$-121.77	$-187.07	$-396.60	$-459.18	$-544.22	$-391.16	$-799.32	$-1.53K	$-782.31	$-986.39	—
Free Cash Flow per Share (USD)	$-1.58	$-1.74	—	$-1.52	—	$-1.49	—	—	—	$-19.30	—	$-26.74	$-141.20	$-212.98	—	—	—	$-380.57	—	—	$-388.91	$-488.83	—
Book Value per Share (USD)	$1.02	$3.84	$1.35	$3.36	$3.82	$4.30	$4.55	$7.72	$11.53	$24.85	—	$82.40	$181.14	$298.27	—	$1.01K	$1.45K	$1.94K	$2.32K	$-3.82K	$-2.58K	$-857.45	—
Tangible Book Value per Share (USD)	$-0.35	$1.86	$-0.91	$2.01	$3.82	$4.30	$4.55	$7.72	$11.53	$24.85	—	$82.40	$181.14	$298.27	—	$1.01K	$1.45K	$1.94K	$2.32K	$-3.82K	$-2.58K	$-857.45	—
Basic Weighted Avg Shares (shares)	3.38M	2.88M	—	1.32M	881,294	596,368	—	364,038	235,773	86,303	—	69,961	17,451	11,832	—	5,691	5,657	5,713	—	1,516	1,396	1,373	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Jan 31, 2022 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$336.00K	$6.04M	$12.36M	$3.10M	$1.02M	$520.00K	$2.37M	$2.60M	$4.07M	$1.83M	$3.25M	—	—	$4.91M	$3.43M	$5.57M	$7.99M	—	$13.07M	—	—	—	—
Total Equity (USD)	$4.25M	$11.06M	$3.41M	$5.59M	$3.69M	$3.04M	$2.54M	$2.83M	$4.19M	$2.15M	$3.58M	$5.76M	$3.16M	$5.21M	$3.63M	$5.77M	$8.19M	$11.09M	$13.27M	$-5.79M	$-3.60M	$-1.18M	$-1.18M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Jan 31, 2022 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	$146.00K	$86.00K	$70.00K	—	$126.00K	$140.00K	$334.00K	$357.00K	$282.00K	$161.00K	$376.00K	$408.00K	$477.00K	$528.00K	$428.00K	$389.00K	$277.00K	$268.00K	$323.00K	—
Depreciation Expense (USD)	$358.00K	$4.00K	$3.00K	$0.00	$1.00K	$1.00K	$0.00	$1.00K	$1.00K	$1.00K	$2.00K	$1.00K	$3.00K	$2.00K	$3.00K	—	—	$2.00K	$2.00K	$2.00K	$2.00K	$2.00K	—
Net Income, GAAP (USD)	$-6.20M	$-6.20M	$-2.85M	$-1.50M	$-1.50M	$-1.50M	$-1.48M	$-1.48M	$-1.48M	$-1.48M	$-2.24M	$-2.12M	$-2.12M	$-2.12M	$-2.25M	$-2.24M	$-2.24M	$-2.24M	$-3.72M	$-1.36M	$-1.36M	$-1.36M	—
Operating Cash Flow (USD)	$-5.28M	$-5.01M	$-2.29M	$-2.00M	—	$-889.00K	$-1.36M	—	—	$-1.67M	$-1.77M	$-1.87M	$-2.44M	$-2.43M	$-2.23M	—	—	$-2.17M	$-2.76M	$-1.64M	$-543.00K	$-665.00K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 23 quarters

Valion Bio, Inc.

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VBIO with peers